GoodRx Appoints Christopher A. McGinnis as Chief Financial Officer
GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced that Christopher A. McGinnis has been appointed as Chief Financial Officer, effective February 4, 2025.
GoodRx's SWOT analysis: stock faces headwinds but growth potential remains
GoodRx Holdings Inc. (NASDAQ:GDRX), a leading healthcare technology company specializing in prescription drug discounts and ...
GoodRx (NASDAQ:GDRX) Shares Gap Down – Should You Sell?
GoodRx Holdings, Inc. (NASDAQ:GDRX – Get Free Report)’s share price gapped down prior to trading on Friday . The stock had previously closed at $4.95, but opened at $4.81. GoodRx shares last traded at ...
GoodRx Announces Date for Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading prescription savings platform in the U.S., today announced it will release its fourth quarter and full year 2024 financial ...